MEDIMMUNE VENTURES
MedImmune Ventures invests in early to late stage, public and private biotechnology companies.
MEDIMMUNE VENTURES
Industry:
Biotechnology Financial Services Venture Capital
Founded:
1987-01-01
Status:
Closed
Technology used in webpage:
Rackspace CSC Global DNS Cvent
Current Employees Featured
Ron Laufer Senior Managing Director @ MedImmune Ventures
Senior Managing Director
Tyrell Rivers Senior Associate @ MedImmune Ventures
Senior Associate
2009-10-01
Franklin H. Top Vice President @ MedImmune Ventures
Vice President
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2016-05-11 | G1 Therapeutics | MedImmune Ventures investment in Series C - G1 Therapeutics | 47 M USD |
| 2015-02-05 | G1 Therapeutics | MedImmune Ventures investment in Series B - G1 Therapeutics | 33 M USD |
| 2014-09-23 | VentiRx Pharmaceuticals | MedImmune Ventures investment in Series B - VentiRx Pharmaceuticals | 50.6 M USD |
| 2013-11-14 | Astria Therapeutics | MedImmune Ventures investment in Series B - Astria Therapeutics | 32.4 M USD |
| 2013-10-16 | G1 Therapeutics | MedImmune Ventures investment in Series A - G1 Therapeutics | 12.6 M USD |
| 2013-09-27 | Inotek Pharmaceuticals | MedImmune Ventures investment in Venture Round - Inotek Pharmaceuticals | 21 M USD |
| 2013-09-27 | Inotek Pharmaceuticals | MedImmune Ventures investment in Debt Financing - Inotek Pharmaceuticals | 7 M USD |
| 2013-02-06 | Astria Therapeutics | MedImmune Ventures investment in Venture Round - Astria Therapeutics | 9 M USD |
| 2012-11-19 | Applied Genetics Technologies Corporation | MedImmune Ventures investment in Series B - Applied Genetics Technologies Corporation | 37.5 M USD |
| 2012-11-06 | Ambit Biosciences | MedImmune Ventures investment in Venture Round - Ambit Biosciences | 50 M USD |
More informations about "MedImmune Ventures"
MedImmune Ventures - Crunchbase Investor Profile & Investments
MedImmune Ventures invests in early to late stage, public and private biotechnology companies.See details»
MedImmune to create stand-alone company for early-stage …
Feb 28, 2018 · AstraZeneca today announced that its global biologics research and development arm, MedImmune, is spinning out six molecules from its early-stage inflammation and …See details»
MedImmune - Crunchbase Company Profile & Funding
MedImmune develops medicines for unmet medical needs worldwide. As the global biologics research and development arm of AstraZeneca, MedImmune is pioneering innovative …See details»
MedImmune Ventures - Investments, Portfolio & Company Exits
MedImmune Ventures invests in early to late stage, public and private biotechnology companies.See details»
MedImmune Ventures - CB Insights
Jun 11, 2020 · MedImmune Ventures primarily seeks to invest in areas of strategic interest to AstraZeneca and MedImmune, including infectious diseases, cancer, inflammatory diseases, …See details»
MedImmune Ventures investment portfolio | PitchBook
MedImmune Ventures was the corporate venture arm of MedImmune. The firm used to invest in private companies which develops small and large molecules, vaccines, pharmaceutical technologies and platforms.See details»
MedImmune Ventures | VentureRadar
MedImmune Ventures, a wholly-owned venture capital fund within the AstraZeneca Group, invests in private companies which develop small and large molecules, vaccines, …See details»
MedImmune Company Profile 2024: Valuation, …
Developer of drugs for prevention and treatment of infectious disease, autoimmune diseases and cancer. The company undertakes the research and development, manufacture and marketing of biologics to address some of the …See details»
MedImmune, Inc. Broadens Focus of Venture Capital Fund to
Jan 7, 2008 · MedImmune Ventures is a corporate venture capital fund with $300 million under management that invests in early-to late-stage, public or private biopharmaceutical companies …See details»
MedImmune Ventures - Case - Harvard Business School
Ron Laufer is the new Senior Managing Director of MedImmune Ventures, the corporate venture capital arm of AstraZeneca, a leading pharmaceuticals firm. Laufer has to decide whether to …See details»
AstraZeneca retires Medimmune name amid sales …
Feb 14, 2019 · After 30 years of drug development, MedImmune will cease to exist as an industry name now that owner AstraZeneca has decided to retire the brand as part of ongoing restructuring efforts. The decision comes a little more …See details»
AstraZeneca pumping $100M more into VC unit | Fierce Biotech
Nov 29, 2011 · As the biotech venture world gets more corporate, AstraZeneca ($AZN) has re-upped its commitment to its MedImmune Ventures group with $100 million in additional funding.See details»
MedImmune Ventures - Teaching Plan - Harvard Business School
"MedImmune Ventures" highlights the problems faced by corporate venture capital firms, the challenges of investing in early-stage healthcare, and the difficulty of operating in distant markets.See details»
MedImmune Ventures - HBR Store
Ron Laufer is the new Senior Managing Director of MedImmune Ventures', the corporate venture capital arm of AstraZeneca, a leading pharmaceuticals firm. Laufer has to decide whether to …See details»
Hanoi - KPMG Vietnam
For more detail about the structure of the KPMG global organization please visit https://kpmg.com/governance.See details»
Xã Mễ Trì Map - Locality - Hanoi, Vietnam - Mapcarta
Xã Mễ Trì Xã Mễ Trì is a locality in Hanoi, Northern Vietnam.Xã Mễ Trì is situated nearby to the quarter Phu Do, as well as near the locality Đinh Thôn.See details»
MedImmune Ventures - Contacts, Employees, Board Members
MedImmune Ventures has 3 current employee profiles, including Senior Managing Director Ron Laufer. MedImmune Ventures invests in early to late stage, public and private biotechnology …See details»
Dining Destinations by JW | Xã Mễ Trì - Facebook
Dining Destinations by JW, Me Tri, Ha Noi, Vietnam. 566 likes · 1 was here. Welcome to dining destinations by JW! Our iconic hotel holds host to three...See details»
Senior Managing Director @ MedImmune Ventures - Crunchbase
Ron Laufer has 2 current jobs as Managing Director at Acuris Partners and Senior Managing Director at MedImmune Ventures. Additionally, Ron Laufer has had 2 past jobs including …See details»
Cốm Mễ Trì Hoà Hà - Facebook
Cốm Mễ Trì Hoà Hà. 1,488 likes · 1 talking about this. Cơ sở sản xuất Cốm Mễ Trì Hoà Hà • Cốm tươi - cốm khô - xôi cốm - chả cốm - xúc xích cốm- bánh...See details»